For their study, the German team enrolled 428 patients with stage cT2 to 4 rectal cancer, dividing the group into high- and low-risk based on a mix of factors, which in turn dictated treatment.

Rectal cancer is relatively common, with about 46,220 new cases diagnosed in the United States each year (27,330 in men and 18,890 in women), according to the American Cancer Society.Deaths from ...

“We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer.” In 20% of non-rectal cancer patients who still needed surgery post-therapy ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, offering patients an alternative to chemotherapy and surgery.

New Research Shows It’s Safe to Watch and Wait Before Surgery To Remove Rectum. Rectal cancer research at MSK and elsewhere shows that watch and wait for localized rectal cancer appears to be just as ...

Background: Patients with locally advanced rectal cancer (LARC) and a clinical complete response (cCR) or near-complete response (nCR) to total neoadjuvant therapy (TNT) can be offered watch-and-wait ...

Dr. Cerek reported that “20% of non-rectal cancer patients” who still had to undergo surgery “saw lower rates of cancer recurrence." She said this suggests that “even if the effect wasn ...

MRI can save rectal cancer patients from surgery, study suggests. ScienceDaily . Retrieved July 12, 2025 from www.sciencedaily.com / releases / 2024 / 10 / 241022104451.htm ...

Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...